Animal Health Institute Announces Leadership Transition
Washington, D.C. – October 21, 2026 – The Animal Health Institute (AHI) announced Martha Scott Poindexter has resigned from her position as Chief Executive Officer of AHI, effective October 20, 2026. The Board thanks Martha Scott for her service and contributions to AHI and its members. We appreciate her commitment to the organization and wish her well in her future endeavors.
The Board appointed Dr. Marie Bucko, AHI’s Chief Operating Officer, as Interim CEO, effective immediately, to provide continuity during the search for AHI’s next CEO.
“On behalf of the Board and member companies, I thank Martha Scott for her contributions to AHI and the animal health industry,” said Jamie Brannan, Chair of the AHI Board and Executive Vice President and Chief Commercial Officer at Zoetis. “We are grateful for her service.”
“Dr. Bucko brings extensive leadership experience, deep knowledge of AHI’s priorities, and a deep commitment to our members,” Brannan added. “We are confident in her leadership during this transition.”
“AHI has a strong foundation, an exceptional staff, and highly engaged members,” said Dr. Bucko. “Our members can be confident that we will provide steady, focused leadership throughout this transition. Together, our team will continue the important work underway and move into 2027 prepared to deliver on AHI’s many priorities.”
The AHI Board of Directors will launch a search for the organization’s next Chief Executive Officer, in due course. AHI’s advocacy, member services, industry engagement, and strategic initiatives will continue without interruption.
About the Animal Health Institute
The Animal Health Institute represents companies developing animal medicines, vaccines, diagnostics, and other animal health products. Since 1941, AHI has advanced research, innovation, animal welfare, food production, and public health.
Please contact AHI for any questions at info@ahi.org.
